Pharmacokinetics and pulmonary extraction of clevidipine, a new vasodilating ultrashort-acting dihydropyridine, during cardiopulmonary bypass

British Journal of Anaesthesia

Volumn 85, Issue 5, 2000, Pages 683-689

  Vuylsteke, A ^a   Milner, Q ^a   Ericsson, H ^b   Mur, D ^a   Dunning, J ^a   Jolin Mellgard A ^b   Nordlander, M ^b   Latimer, R ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Pharmacokinetics, clevidipine; Surgery, cardiovascular

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOPLEGIC AGENT; CLEVIDIPINE; DIHYDROPYRIDINE; FENTANYL; ISOFLURANE; MIDAZOLAM; MORPHINE; NITROPRUSSIDE SODIUM; OXYGEN; PANCURONIUM; REMIFENTANIL; SCOPOLAMINE; VASODILATOR AGENT;

AREA UNDER THE CURVE; ARTERIAL BLOOD; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE REGULATION; BODY TEMPERATURE; BOLUS INJECTION; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARTMENT MODEL; DATA ANALYSIS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG METABOLISM; DRUG TISSUE LEVEL; ENZYME ACTIVITY; FEMALE; HEART SURGERY; HUMAN; HYPOTHERMIA; LOW TEMPERATURE; MALE; PLASMA CLEARANCE; PRIORITY JOURNAL; VASODILATATION; VENOUS BLOOD;

EID: 0033760624     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/85.5.683     Document Type: Article

References (31)

1. Anaesthesia for coronary artery surgery-a plea for a goal-directed approach
2. The effects of anesthetic technique on the hemodynamic response and recovery profile in coronary revascularization patients
3. Systemic hypertension following myocardial revascularization
4. Postoperative myocardial ischemia. Therapeutic trials using intensive analgesia following surgery
5. Does perioperative myocardial ischemia lead to postoperative myocardial infarction?
6. Acute hypertension immediately after coronary artery surgery
7. Neuropathologic complications of cardiac surgery
8. Pressure-dependent cerebral ischemia during cardiopulmonary bypass
9. Calcium antagonists for perioperative blood pressure control
10. Antihypertensive and anti-ischemic effects of nicardipine and nitroprusside in patients undergoing coronary artery bypass grafting
11. Treatment of perioperative hypertension
12. Sodium nitroprusside: Twenty years and counting
13. Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers
14. In vitro hydrolysis rate and protein binding of clevidipine, a new ultrashort-acting calcium antagonist metabolised by esterases, in different animal species and man
15. Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusion
16. Pharmacokinetics and arteriovenous differences in clevidipine concentration following short- and a long-term intravenous infusion in healthy male volunteers
17. Circulatory effects and pharmacology of clevidipine, a novel ultra short acting and vascular selective calcium antagonist, in hypertensive humans
18. Coronary and systemic hemodynamic effects of clevidipine for treatment of hypertension after coronary artery surgery
19. Effect of temperature and cardiopulmonary bypass on the pharmacokinetics of remifentanil
20. Effect of hypothermia and sampling site on blood esmolol concentrations
21. Use of dodecyl sulfate as an esterase inhibitor before gas-chromatographic determination of labile β-adrenoceptor blocking drugs
22. Determination of an ultrashort-acting antihypertensive dihydropyridine in blood using capillary gas chromatography mass spectrometry and of the primary metabolite using liquid chromatography and fluorescence detection
23. Population kinetics and conditional assessment of the optimal dosage using the P-PHARM software package
24. Linear pharmacokinetic equation allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data
25. Remifentanil and pulmonary extraction during and after cardiac anesthesia
26. Some considerations on the estimation of steady state apparent volume of distribution and the relationships between volume terms
27. Parameter and structural identifiability concepts and ambiguities: A critical review and analysis
28. General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics
29. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease
30. Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation
31. Baroreceptor reflex control of heart rate during isoflurane anesthesia in humans